Answers are grounded in this paper and cite their sources.
More than half of new drugs entering the German healthcare system have not been shown to add benefit. Beate Wieseler and colleagues argue that international drug development processes and policies are responsible and must be reformed
No takes yet. Share an insight, caveat, or question.
Wieseler et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: